PHARMACOLOGY Correction for “From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection,” by Shalley N. Kudalkar, Jagadish Beloor, Elias Quijano, Krasimir A. Spasov, Won-Gil Lee, José A. Cisneros, W. Mark Saltzman, Priti Kumar, William L. Jorgensen, and Karen S. Anderson, which was first published December 26, 2017; 10.1073/pnas.1717932115 (Proc Natl Acad Sci USA 115:E802–E811).
The authors would like to note that the conflict of interest statement should state, “W.L.J. and K.S.A. are listed as the inventors on a patent issued to Yale University on the intellectual property associated with compound I [US Patent 9,382,245 (2016)].”
